Oncopeptides at Congresses: Driving Progress in Multiple Myeloma
Scientific congresses are key moments for Oncopeptides to engage with the hematology community and advance care in multiple myeloma. Our participation reflects a deep commitment to innovation, collaboration, and improving patient outcomes. We’re proud to contribute to the dialogue shaping the future of treatment—and we invite you to meet us on-site to explore what’s next, together.
For more information, please contact our Product Project Director:
Astrid Rydheim
astrid.rydheim@oncopeptides.com
Below we have listed the congresses that Oncopeptides will attend.